I’m excited to announce that Sugarmate will be joining the Tandem Diabetes Care family!
As most people in the community know, Tandem is a leading diabetes management company, and the maker of the t:slim X2 insulin pump with Control-IQ technology. Their strong commitment to improving the lives of people with diabetes makes them a great home for Sugarmate's platform. Tandem shares Sugarmate's vision for the product's future, and this acquisition will allow us to continue to innovate and carry out our mission. We have a lot of exciting features on our roadmap that we are continuing to move forward.
In the near term, nothing will change. Sugarmate will continue to serve its current customers and operate as a standalone entity. Existing Sugarmate app users, and anyone wanting to use the platform, will continue to go through the Sugarmate app or website for information or guidance. Tandem is committed to supporting the Sugarmate user community regardless of their choice of insulin therapy.
I’m sure you have many questions and I've attempted to answer some here. Tandem and Sugarmate will provide updates as we have them.
I want to give a sincere thank you to the Sugarmate community. We wouldn’t have reached this milestone without you, and I am confident that Tandem is the right company to help Sugarmate continue to develop innovative features and better service the diabetes community.